Valuation : Novartis AG

Market Cap 29TCr 25TCr 24TCr 22TCr 40TCr 27,76000Cr 41TCr 2,79300Cr 1,09000Cr 14,04000Cr 1,09300Cr 1,06900Cr 46,58800Cr P/E 2026 *
21.8x
P/E 2027 * 18.6x
Enterprise Value 32TCr 28TCr 26TCr 24TCr 45TCr 30,87600Cr 45TCr 3,10600Cr 1,21300Cr 15,61600Cr 1,21600Cr 1,18900Cr 51,81800Cr EV / Sales 2026 *
5.62x
EV / Sales 2027 * 5.2x
Free-Float
91.66%
Yield 2026 *
2.85%
Yield 2027 * 2.98%
1 day-0.54%
1 week-1.56%
Current month-1.50%
1 month-1.47%
3 months+1.78%
6 months-8.78%
Current year+11.56%
1 week 152.77
Extreme 152.77
160.29
1 month 149.09
Extreme 149.09
160.81
Current year 135.55
Extreme 135.55
170.46
1 year 121.57
Extreme 121.57
170.46
3 years 92.19
Extreme 92.19
170.46
5 years 74.09
Extreme 74.09
170.46
10 years 66.93
Extreme 66.93
170.46
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%-1.56% - - 29TCr
-0.13%-5.61%+59.99%+112.16% 1,04800Cr
+0.85%+0.25%+51.61%+61.23% 64TCr
-1.03%-2.43%+22.79%+74.16% 46TCr
-1.46%-3.52%+36.60%+38.39% 36TCr
-0.72%-2.06%+21.34%+37.92% 29TCr
-1.19%-0.98%+0.79%+12.29% 26TCr
-1.05%-0.30%+50.16%+68.66% 24TCr
+0.08%-0.22%-17.16%-53.76% 20TCr
-2.14%+1.56%+27.88%+89.54% 18TCr
Average -0.64%-0.72%+28.22%+48.95% 40.91TCr
Weighted average by Cap. -0.33%-1.92%+37.92%+65.36%

Financials

2026 *2027 *
Net sales 5.76TCr 4.98TCr 4.67TCr 4.26TCr 8.01TCr 5,49700Cr 8.05TCr 55TCr 22TCr 2,78000Cr 22TCr 21TCr 9,22600Cr 6.13TCr 5.29TCr 4.96TCr 4.53TCr 8.52TCr 5,84600Cr 8.56TCr 59TCr 23TCr 2,95700Cr 23TCr 23TCr 9,81200Cr
Net income 1.4TCr 1.2TCr 1.13TCr 1.03TCr 1.94TCr 1,33000Cr 1.95TCr 13TCr 5.22TCr 67TCr 5.24TCr 5.12TCr 2,23300Cr 1.55TCr 1.34TCr 1.25TCr 1.15TCr 2.16TCr 1,47800Cr 2.17TCr 15TCr 5.81TCr 75TCr 5.82TCr 5.69TCr 2,48100Cr
Net Debt 3.27TCr 2.82TCr 2.64TCr 2.41TCr 4.54TCr 3,11600Cr 4.56TCr 31TCr 12TCr 1,57600Cr 12TCr 12TCr 5,23000Cr 2.78TCr 2.4TCr 2.25TCr 2.06TCr 3.87TCr 2,65300Cr 3.89TCr 27TCr 10TCr 1,34200Cr 10TCr 10TCr 4,45200Cr
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
28/26/28 $153.81 -0.54% 11,65,866
27/26/27 $154.65 -1.83% 12,20,734
26/26/26 $157.54 -1.53% 14,73,550
25/26/25 $159.98 +1.24% 9,98,182
24/26/24 $158.02 -0.53% 8,01,260
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
153.16USD
Average target price
154.32USD
Spread / Average Target
+0.76%

Quarterly revenue - Rate of surprise